4-tert-butyl-calix[4]arene-crown-5-complex

Modify Date: 2024-01-14 20:03:08

4-tert-butyl-calix[4]arene-crown-5-complex Structure
4-tert-butyl-calix[4]arene-crown-5-complex structure
Common Name 4-tert-butyl-calix[4]arene-crown-5-complex
CAS Number 99314-01-9 Molecular Weight 636.85900
Density N/A Boiling Point N/A
Molecular Formula C42H52O5 Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name 4-tert-butyl-calix[4]arene-crown-5-complex
Synonym More Synonyms

 Chemical & Physical Properties

Molecular Formula C42H52O5
Molecular Weight 636.85900
Exact Mass 636.38100
PSA 46.15000
LogP 7.74370

 MSDS

Name: 4-Tert.-Butyl-Calix[4]Arene-Crown-5-Complex Material Safety Data Sheet
Synonym: None Known
CAS: 99314-01-9
Section 1 - Chemical Product MSDS Name:4-Tert.-Butyl-Calix[4]Arene-Crown-5-Complex Material Safety Data Sheet
Synonym:None Known

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
99314-01-9 4-Tert.-Butyl-Calix[4]Arene-Crown-5-Co 97 unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea.
Inhalation:
Causes respiratory tract irritation. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or alcohol-resistant foam. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 99314-01-9: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: white - grey
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Not available.
Specific Gravity/Density:
Molecular Formula: C52H70O7
Molecular Weight: 806.4858

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 99314-01-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Tert.-Butyl-Calix[4]Arene-Crown-5-Complex - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 99314-01-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 99314-01-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 99314-01-9 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Safety Information

Hazard Codes Xi
Risk Phrases R36/37/38
Safety Phrases S26-S37/39

 Synthetic Route

 Synonyms

4-TERT-BUTYLCALIX(4)-CROWN-5
25,27-(3,6,9-trioxaundeca-1,11-diyl)oxy-26,28-dihydroxy-5,11,17,23-tetra-tert-butyl-calix[4]arene
p-ter-Butylcalix[4]arene-crown-5
5,11,17,23-Tetrakis(1,1-dimethylethyl)-25,27-(crown-5)-26,28-dihydroxycalix[4]arene
2,20,25,35-tetrakis(1,1-dimethylethyl)-6,7,9,10,12,13,15,16-octahydro-28H-4,18-(methano<1,3>benzenomethano)-23,27-metheno-22H-dibenzo<n,w><1,4,7,10,13>pentaoxycyclotetracosin-29,32-diol
p-tert-butylcalix<4>crown-5
5,11,17,23-tetrakis(1,1-dimethylethyl)-25,27-dihydroxycalix[4]arene-crown-5
5,11,17,23-tetra-tert-butyl-25,27-dihydroxy-26,28-(3',6',9'-trioxaundecylene)dioxy-calix<4>arene
MFCD02093903
Top Suppliers:I want be here

No recommended suppliers.

Related Compounds: More...
4-tert-butyl-calix[4]arene-crown-4-complex
171058-95-0
4-tert-butyl-calix[4]arene-crown-6-complex
129518-51-0
4-tert-butyl-calix[4]arene tetra-n-propyl ether
135269-36-2
4-tert-Butylcalix[5]arene-crown-5-complex
151412-40-7
4-tert-butyl-4,5,6,7-tetrahydro-5-benzofuranone
115483-21-1
4-(tert-butyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]phosphepine
515811-32-2
4-tert-butyl-4,5-dihydro-pyrazole-3,3-dicarbonitrile
22150-66-9
5,11,17,23-tetra-tert-butyl-25,26,27,28-tetrakis[(ethoxycarbonyl)methoxy]-2,8,14,20-calix[4]arene
121702-03-2
5,11,17,23-tetra-tert-butyl-25,27-dibenzoyloxy-26,28-dihydroxycalix[4]arene
161316-47-8
5-(dimethylcarbamoyl)-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperidine-2-carboxylic acid
2137505-79-2
tert-butyl N-{4-[(2S)-2-hydroxypropyl]-2-methylphenyl}carbamate
2227801-74-1
5-(tert-Butyl)-N-(2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)-1,2,4-oxadiazole-3-carboxamide
2641807-41-0
3-[(4-Chloro-3-methylphenyl)methyl]thietan-3-ol
2171823-14-4
1,5-di-tert-butyl 3-iodo-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-1,5-dicarboxylate
2680786-22-3
4-(aminomethyl)-N-(3-chloro-2-methylphenyl)pyrimidin-2-amine
2110839-02-4
(2S)-3-(dimethylamino)-2-[3-ethoxy-4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanamido]propanoic acid
2171323-48-9
2-(4,4-Difluoropiperidine-1-carbonyl)-4-(4-methylpyrimidin-2-yl)morpholine
2742070-15-9
2-{[(Benzyloxy)carbonyl]amino}-5-ethoxy-4-methoxybenzoic acid
2287334-37-4
rac-(1R,2R)-2-[2-(pyrrolidin-1-yl)pyridin-3-yl]cyclopropane-1-carboxylic acid
2227746-53-2